十年的FDA烟草法规:给公共卫生利益相关者的教训。

Desmond Jenson
{"title":"十年的FDA烟草法规:给公共卫生利益相关者的教训。","authors":"Desmond Jenson","doi":"10.1080/01947648.2020.1868940","DOIUrl":null,"url":null,"abstract":"<p><p>In the 10 years that the U.S. Food and Drug Administration (FDA) has been regulating tobacco products, the agency has been plagued with setbacks, some of its own making, and some the result of outside forces. What has been consistently true is that the public health community has not had as much of a voice as it should have until public health groups began filing lawsuits against the FDA. This article examines four areas of FDA regulation over the last decade in an attempt to qualitatively describe the work of the Center for Tobacco Products and identify opportunities for public health groups to have greater advocacy success in the future.</p>","PeriodicalId":520806,"journal":{"name":"The Journal of legal medicine","volume":" ","pages":"335-353"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/01947648.2020.1868940","citationCount":"1","resultStr":"{\"title\":\"Ten Years of FDA Tobacco Regulation: Lessons for Public Health Stakeholders.\",\"authors\":\"Desmond Jenson\",\"doi\":\"10.1080/01947648.2020.1868940\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the 10 years that the U.S. Food and Drug Administration (FDA) has been regulating tobacco products, the agency has been plagued with setbacks, some of its own making, and some the result of outside forces. What has been consistently true is that the public health community has not had as much of a voice as it should have until public health groups began filing lawsuits against the FDA. This article examines four areas of FDA regulation over the last decade in an attempt to qualitatively describe the work of the Center for Tobacco Products and identify opportunities for public health groups to have greater advocacy success in the future.</p>\",\"PeriodicalId\":520806,\"journal\":{\"name\":\"The Journal of legal medicine\",\"volume\":\" \",\"pages\":\"335-353\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/01947648.2020.1868940\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of legal medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/01947648.2020.1868940\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of legal medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/01947648.2020.1868940","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

在美国食品和药物管理局(FDA)监管烟草产品的10年里,该机构一直受到挫折,有些是自己造成的,有些是外部力量的结果。一直以来的事实是,直到公共卫生组织开始对FDA提起诉讼,公共卫生界才有了应有的发言权。本文考察了过去十年中FDA法规的四个方面,试图定性地描述烟草产品中心的工作,并确定公共卫生组织在未来取得更大宣传成功的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Ten Years of FDA Tobacco Regulation: Lessons for Public Health Stakeholders.

In the 10 years that the U.S. Food and Drug Administration (FDA) has been regulating tobacco products, the agency has been plagued with setbacks, some of its own making, and some the result of outside forces. What has been consistently true is that the public health community has not had as much of a voice as it should have until public health groups began filing lawsuits against the FDA. This article examines four areas of FDA regulation over the last decade in an attempt to qualitatively describe the work of the Center for Tobacco Products and identify opportunities for public health groups to have greater advocacy success in the future.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Comprehensive Analysis of Malpractice Claims Following Management of Hip Fractures. A Review of Medical and Legal Characteristics for Urethroplasty-Related Litigation and Medical Malpractice Cases. Risks of Improper Stimulant Prescribing With Telemedicine-Only Platforms. Editor's Note. The Influence of a Medical-Legal Partnership on Self-Reported Health Outcomes in Upstate New York.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1